Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: admit for planned surgery major surgical or invasive procedure: left colectomy small bowel resection excision of retroperitoneal mass left uretero-ureterostomy history of present illness: 51-year-old female with sigmoid lesion discovered during surveillance colonoscopy for reassessment of sessile polyp. family history of colon cancer, biopsy proven hyperplasia, plastic polyp at 50 cm with 270 degree growing sessile lesions at approximately 35 cm. pt underwent sigmoid colectomy in , and presented recently with new-onset l leg weakness. evaluation revelaed a large mass from the l colon invading the psoas muscle. she is admitted for subtotal colectomy and possible colostomy. past medical history: 1. colon ca s/p sigmoid colectomy in '. no chemo or rad tx. 2. report of multiple episodes of bleeding; hematologic workup and two workups for vwf have been normal. 3. uterine ca s/p tah bso 4. htn 5. anxiety/depression 7. cervical neuropathy 8. hep c 9. oa 10. asthma 11. h/o etoh abuse 12. ccy 13. appendectomy 14. tonsillectomy 15. ventral hernia repair social history: quit tob and etoh last month. etoh: pint of rum 2-3x/week. on nicotine patch. no ivdu. on disability. lives with daughter, granddaughter, and ex-husband. family history: non-contributory physical exam: physical exam on discharge: vs: 98.0 103 110/70 20 96%ra regular rate and rhythm clear lung fields abd soft, mildly distended, with good healing of surgical incision. pertinent results: 11:50am blood hct-23.6* 12:10am blood wbc-14.7* rbc-3.65* hgb-10.6* hct-30.5* mcv-84 mch-29.1 mchc-34.8 rdw-15.9* plt ct-303 07:28pm blood hct-26.9* 04:59am blood wbc-13.2* rbc-3.40* hgb-9.8* hct-29.5* mcv-87 mch-29.0 mchc-33.4 rdw-16.0* plt ct-475* brief hospital course: pt admitted on day of surgery. she tolerated the procedure well and was transferred to the sicu post-operatively, as she remained intubated. she was extubated on , and continued to do well. on , it was noted that her hematocrit had dropped to 23 from 30, and she was transfused 2 units. no source of bleeding was found after extensive examination. pt's sicu course was otherwise uneventful, and she was transferred to the floor on . here she continued to do well, with stable crits, vital signs, and a generally reassuring course. although the output from her - drain remained elevated, the creatinine of this fluid was reassuring that there was no urine leak, and the drain was removed. she began tolerating oral intake on , and by was doing very well. she was discharged home with services, and instructed to return to clinic for follow up. medications on admission: 1. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. 2. nicotine 14 mg/24 hr patch 24hr sig: one (1) patch 24hr transdermal daily (daily). 3. lisinopril 5 mg tablet sig: 0.5 tablet po daily (daily). 4. metoprolol succinate 50 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 5. venlafaxine hcl 75 mg capsule, sust. release 24hr sig: one (1) capsule, sust. release 24hr po daily (daily). discharge medications: 1. albuterol 90 mcg/actuation aerosol sig: 1-2 puffs inhalation q6h (every 6 hours) as needed. 2. nicotine 14 mg/24 hr patch 24hr sig: one (1) patch 24hr transdermal daily (daily). 3. lisinopril 5 mg tablet sig: 0.5 tablet po daily (daily). 4. zolpidem tartrate 5 mg tablet sig: two (2) tablet po hs (at bedtime) as needed. 5. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed. disp:*40 tablet(s)* refills:*0* 6. metoprolol succinate 50 mg tablet sustained release 24hr sig: one (1) tablet sustained release 24hr po daily (daily). 7. pantoprazole sodium 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 8. venlafaxine hcl 75 mg capsule, sust. release 24hr sig: one (1) capsule, sust. release 24hr po daily (daily). discharge disposition: home with service facility: homecare discharge diagnosis: metastatic adenocarcinoma of colon discharge condition: good discharge instructions: please keep wound area clean. please perform sterile wet to dry dressing changes with sterile saline water twice daily to open wound area. take medications as prescribed. followup instructions: please call dr. office at within one week after discharge to schedule a follow-up appointment. please call dr office in wks for f/u and removal of ureteral stent. md, procedure: other partial resection of small intestine open and other left hemicolectomy excision or destruction of peritoneal tissue ureteral catheterization transfusion of packed cells transureteroureterostomy diagnoses: unspecified essential hypertension secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes secondary malignant neoplasm of retroperitoneum and peritoneum malignant neoplasm of other specified sites of large intestine other ureteric obstruction secondary malignant neoplasm of other urinary organs 

Answer: The patient is high likely exposed to